Cost-effectiveness analysis favors epoetin alfa to front-loaded regimens of darbepoetin alfa and dominates every other week dosing of darbepoetin alfa.

被引：0
|
作者：
Frame, D
Fastenau, JM
Piech, CT
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Dept Pharm, Chicago, IL USA
[2] Ortho Biotech Prod LP, Clin Affairs, Bridgewater, NJ USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5776
引用
收藏
页码：511B / 511B
页数：1
相关论文
共 50 条
  • [1] The Impact of Methodological Approach on Cost Findings in Comparison of Epoetin Alfa with Darbepoetin Alfa.
    Song, Xue
    Long, Stacey R.
    Marder, William D.
    Sullivan, Sean D.
    Kallich, Joel
    BLOOD, 2008, 112 (11) : 469 - 470
  • [2] Comparing the cost-effectiveness of front loaded darbepoetin alfa with epoetin alfa for anemia management in chemotherapy-treated cancer patients in United States
    Glaspy, J
    Tchekmedyian, N
    Gupta, S
    VALUE IN HEALTH, 2002, 5 (06) : 538 - 538
  • [3] COST-EFFECTIVENESS MODELLING OF EPOETIN ALFA AND DARBEPOETIN ALFA IN THE TREATMENT OF CHEMOTHERAPY-RELATED ANAEMIA IN SWEDEN
    Liwing, J.
    Nasman, P.
    Kernell, H.
    Gagnon, D. D.
    Wu, Y.
    VALUE IN HEALTH, 2010, 13 (03) : A38 - A38
  • [4] Cost-effectiveness of once weekly epoetin alfa and darbepoetin alfa in treating chemotherapy-induced anemia
    Ben-Hamadi, R
    Duh, MS
    Aggarwal, J
    Henckler, A
    McKenzie, S
    Fastenau, J
    Piech, CT
    VALUE IN HEALTH, 2005, 8 (03) : 238 - 238
  • [5] The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia
    Ben-Hamadi, R
    Duh, MS
    Aggarwal, J
    Henckler, A
    McKenzie, RS
    Piech, CT
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (10) : 1677 - 1682
  • [6] Cost-minimization analysis of darbepoetin alfa versus epoetin alfa in the hospital setting
    Kruep, EJ
    Basskin, LE
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (24) : 2597 - 2603
  • [7] Cost-effectiveness of once weekly epoetin alfa and darbepoetin alfa in treating chemotherapy-induced anemia.
    Ben-Hamadi, R
    Duh, MS
    Henchler, A
    McKenzie, S
    Fastenau, J
    Piech, CT
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 551S - 551S
  • [8] Cost-effectiveness analysis of Aranesp® (darbepoetin alfa) administered once every three weeks compared to once every week
    Demarteau, N
    Annemans, L
    VALUE IN HEALTH, 2005, 8 (06) : A37 - A37
  • [9] A Randomized Comparison of Standard Weekly Epoetin Alfa to Every-3-Week Epoetin Alfa and Every-3-Week Darbepoetin Alfa: A Study of the Mayo Clinic Cancer Research Consortium (MCCRC)
    Steensma, David P.
    Dakhil, Shaker R.
    Novotny, Paul J.
    Sloan, Jeff A.
    Johnson, David B.
    Anderson, Daniel. M.
    Mattar, Bassani I.
    Moore, Dennis F., Jr.
    Nikcevich, Daniel
    Loprinzi, Charles L.
    BLOOD, 2009, 114 (22) : 1172 - 1172
  • [10] Extended dosing with darbepoetin alfa administered every other week or once monthly in haemodialysis patients with CKD
    Trachsler, Johannes
    Burkhalter, Felix
    Gauthier, Thierry
    Bruenisholz, Michel
    Saldutto, Biagio
    Dickenmann, Michael
    Wuethrich, Rudolf
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 350 - 350
12345